Sepsis: Page 4

Inflammatix wins $1.7M NIH grant
By LabPulse.com staff writers
Using host immune mRNA signatures, the company has identified three sepsis subtypes ("endotypes"). The NIH award will allow Inflammatix to further investigate each endotype's signature and to develop a rapid, 30-minute test to identify them, it said.
November 14, 2021
2019 04 26 21 48 5250 Money Hundred Bills 400
Prenosis, Roche expand partnership to combat sepsis
By LabPulse.com staff writers
The companies will build on a collaboration they began in 2020. Prenosis will significantly expand its core NOSIS dataset, a large and growing hybrid biomarker-clinical dataset for sepsis care. In addition, the two companies will work together to obtain U.S. Food and Drug Administration clearance for the Prenosis Sepsis Immunoscore and the Roche Elecsys IL-6 assay.
October 13, 2021
2019 07 15 17 19 4107 Bacteria Blood Sepsis 400
AAD secures BARDA contract for early sepsis detection test
By LabPulse.com staff writers
QScout RLD+ can be used in urgent care clinics, doctor's offices, and other nonhospital settings, the company said. It is a rapid hematology analyzer that can describe a seven-part leukocyte differential, including quantifying band neutrophils and other immature granulocytes which can indicate severe infection. Results are available in two minutes compared to the two hours often required by a hospital's testing protocol, according to AAD.
October 5, 2021
2019 07 15 17 19 4107 Bacteria Blood Sepsis 400
Flu shots may protect against severe COVID-19
By LabPulse.com staff writers
The annual flu shot may reduce the risks of stroke, sepsis, and deep vein thrombosis (DVT) in patients with COVID-19. Also, those who received influenza vaccines were significantly less likely to visit emergency departments and be admitted to intensive care units, according to the findings.
August 3, 2021
2021 08 04 21 10 9313 Senior Elderly Vaccine 400
Ortho launches IL-6 reagent pack
By LabPulse.com staff writers
Conditions that can be targeted by the test include autoimmune disorders, sepsis, severe respiratory infections from COVID-19, and community-acquired pneumonia in critically ill patients.
July 22, 2021
2020 06 18 17 24 6922 Immunoassay Analysis 400
NanoDx inks deal with IBM, seeks EUA for COVID-19 test
By LabPulse.com staff writers
Under the deal, NanoDx will get use of IBM's complementary metal oxide semiconductor (CMOS)-compatible nanoscale sensors to enhance and expand rapid testing for conditions such as sepsis, stroke, traumatic brain injury, and COVID-19.
July 13, 2021
2020 02 13 23 04 0191 Lab Scientists 400
CMS continues NTAP for T2's bacteria panel in FY 2021
By LabPulse.com staff writers
The extension allows U.S. hospitals treating sepsis patients who are covered by Medicare to remain eligible for an NTAP of $97.50 for the T2Bacteria panel. This payment covers 65% of the average cost of the test panel, which detects pathogens that cause sepsis, for eligible patients, according to the company.
September 22, 2020
2019 10 30 21 49 9027 Cms Building 400
Sphingotec launches point-of-care biomarker test for sepsis, COVID-19
By LabPulse.com staff writers
Bio-ADM blood levels reflect in real time the functional status of the endothelium. Endothelial function failure precedes edema and the life-threatening blood pressure drop that causes shock and multiorgan failure -- for instance in sepsis patients. Recent data also show that elevated bio-ADM blood levels identify patients in the general intensive care unit (ICU) patient population who require immediate life-saving therapeutic interventions. Monitoring endothelial function can also help in identifying COVID-19 disease progression.
July 23, 2020
2020 04 16 15 33 7995 New Product 400
Immunexpress to develop sepsis test with BARDA grant
By LabPulse.com staff writers
The grant from BARDA, which is an office of the U.S. Department of Health and Human Services, will cover development and filing for a U.S. Food and Drug Administration emergency use authorization for the host response sepsis test SeptiCyte Rapid.
June 18, 2020
2020 06 19 20 57 0712 Sepsis Bacteria 400
Procalcitonin test signals infection in heart attack patients
By Emily Hayes
As an important marker for inflammation in the body, a blood test for PCT is useful for systemic bacterial infections and sepsis. But its value for detecting infection in patients with acute ST-elevation myocardial infarction (STEMI) -- an area of unmet need -- has been unclear. One key question is whether it is specific enough for infection, or whether levels would increase due to cardiac injury -- a limitation of other inflammatory biomarkers such as C-reactive protein (CRP) and white blood cell counts.
June 15, 2020
2020 06 12 22 02 7866 Procalcitonin Test 400
Beckman Coulter debuts new tabletop hematology analyzer
By LabPulse.com staff writers
Targeted at mid-volume laboratories, DxH 690T provides similar functionality as Beckman Coulter's flagship DxH 900 large-volume hematology analyzer, but in a tabletop configuration, according to the vendor. The DxH 690T supports Beckman Coulter's Early Sepsis Indicator test for identifying adult patients who either have sepsis or have an increased risk of developing the life-threatening condition, as part of a standard complete blood count (SBC) with differential.
May 19, 2020
2020 05 19 22 18 2599 Beckman Coulter Dx H 690 T 400
Cytovale tests sepsis diagnostic in COVID-19 patients
By LabPulse.com staff writers
BARDA, which is an office within the U.S. Department of Health and Human Services, is contributing $3.83 million out of the $5.9 million needed for validation and advanced research of Cytovale's rapid sepsis diagnostic system, including the COVID-19 pilot study, and Cytovale is footing the bill for the remainder.
April 22, 2020
2019 07 15 17 19 4107 Bacteria Blood Sepsis 400
Previous Page
Page 4 of 6
Next Page